Roche Diagnostics Announces $550M Expansion in Indianapolis
Roche Diagnostics has announced it will invest up to $550 million in its Indianapolis-based operations over the next five years, adding hundreds of skilled jobs and establishing the city as a global manufacturing center for the company’s continuous glucose monitoring (CGM) system. Roche’s Indianapolis campus currently employs 4,815 people and already serves as one of two global distribution hubs for the company, supporting shipments to 53 countries.
